Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Cancers|November 8, 2019
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple MyelomaSiyang Yan, Niels Vandewalle, Nathan De Beule, et al.
Frontiers in Immunology|October 28, 2022
The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancersRong Fan, Nathan De Beule, Anke Maes, et al.
Blood|December 1, 2011
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibitionJinsong Hu, Nana Dang, Eline Menu, et al.
Blood|January 21, 2010
IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanismsElke De Bruyne, Tomas J Bos, Frans Schuit, et al.
Oncotarget|May 17, 2014
The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myelomaKen Maes, Eva De Smedt, Miguel Lemaire, et al.
Cancer Letters|January 9, 2026
The clinically available supplement pyruvate enhances the therapeutic effect of bortezomib in MM by modulating mitochondrial metabolismChenggong Tu, Arne Van der Vreken, Sylvia Faict, et al.
Experimental Hematology & Oncology|October 4, 2024
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategiesNiels Vandewalle, Nathan De Beule, Ann De Becker, et al.
Blood|June 15, 2014
Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cellsJinheng Wang, An Hendrix, Sophie Hernot, et al.
International Journal of Molecular Sciences|January 21, 2022
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future DirectionsEmma Verheye, Jesús Bravo Melgar, Sofie Deschoemaeker, et al.
Frontiers in Oncology|December 25, 2014
Myeloid-derived suppressor cells as therapeutic target in hematological malignanciesKim De Veirman, Els Van Valckenborgh, Qods Lahmar, et al.
Pageof 17